β-Adrenoceptor Agonist Clenbuterol Down-Regulates Matrix Metalloproteinase (MMP-9) and Results in an Impairment of Collagen Turnover in Mice Left Ventricle

書誌事項

タイトル別名
  • .BETA.-Adrenoceptor Agonist Clenbuterol Down-Regulates Matrix Metalloproteinase (MMP-9) and Results in an Impairment of Collagen Turnover in Mice Left Ventricle
公開日
2005
DOI
  • 10.2170/jjphysiol.r2118
公開者
一般社団法人 日本生理学会

この論文をさがす

説明

An oral administration of a single dose of β-adrenoceptor agonist clenbuterol (15 mg/kg body weight) to mice resulted in an increased collagen distribution in the subendocardium and myocardium of the left ventricle. Abundant collagen accumulation is characteristic in myonecrotic regions and around blood vessels. Hydroxyproline assay and sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) of pepsin insoluble collagen confirmed this stimulated collagen proliferation. An MMP-activity assay of tissue extract by gelatin in gel zymography demonstrated a significant inhibition of MMP-9 activity in the β-agonist–treated group. The results suggest that clenbuterol treatment is capable of inducing structural and functional remodeling of the extracellular matrix by down-regulating MMP-9 activity and thereby causing an impairment of collagen turnover. This may lead to changes in the different hemodynamic properties of the tissue, including ventricular compliance.<br>

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (23)*注記

もっと見る

詳細情報 詳細情報について

  • CRID
    1390001205043665664
  • NII論文ID
    130004435927
  • DOI
    10.2170/jjphysiol.r2118
  • ISSN
    18811396
    0021521X
  • 本文言語コード
    en
  • データソース種別
    • JaLC
    • Crossref
    • CiNii Articles
  • 抄録ライセンスフラグ
    使用不可

問題の指摘

ページトップへ